Myriad Genetics Inc.

NASDAQ: MYGN · Real-Time Price · USD
5.71
-0.18 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
5.66
-0.96%
After-hours: Aug 15, 2025, 05:30 PM EDT

Myriad Genetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-127.3M -263.3M -112M -27.2M
Depreciation & Amortization
61.2M 61.9M 52.7M 62.8M
Stock-Based Compensation
49.8M 40.7M 38.1M 36.3M
Other Working Capital
-44.2M 28.7M -84.8M 118.8M
Other Non-Cash Items
62.3M 23.4M 30.3M -139.4M
Deferred Income Tax
-300K -600K -31.9M -34.7M
Change in Working Capital
-54.4M 27M -83.5M 120.8M
Operating Cash Flow
-8.7M -110.9M -106.3M 18.6M
Capital Expenditures
-29.7M -73.3M -45.3M -18M
Cash Acquisitions
8.8M n/a -57.2M 379.1M
Purchase of Investments
n/a n/a -103.2M -147.8M
Sales Maturities Of Investments
9M 105.2M 128.2M 61.1M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-11.9M 31.9M -77.5M 274.4M
Debt Repayment
100K 39.8M n/a -226.4M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-7.5M -4.5M -8M 75.8M
Financial Cash Flow
-7.4M 152.9M -8M -150.6M
Net Cash Flow
-29M 74.5M -192.4M 141.8M
Free Cash Flow
-38.4M -184.2M -151.6M 600K